Yoichi Nishiya Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

1/2020

The novel potent TEAD inhibitor, K-975, inhibits YAP1/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoichi Nishiya Research Topics

Disease

2	Type 2 Diabetes Mellitus (MODY) 02/2023 - 01/2023
2	Overactive Urinary Bladder (Overactive Bladder) 01/2014 - 11/2011
1	Heart Failure 02/2024
1	Anemia 02/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Malignant Mesothelioma 01/2020
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2014

Drug/Important Bio-Agent (IBA)

3	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 01/2023
2	SodiumIBA 02/2023 - 01/2023
2	empagliflozinIBA 02/2023 - 01/2023
2	SymportersIBA 02/2023 - 01/2023
2	KW 7158IBA 01/2014 - 11/2011
1	Biomarkers (Surrogate Marker)IBA 02/2024
1	LinagliptinIBA 02/2023
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Neurofibromin 2 (Merlin)IBA 01/2020
1	draflazineIBA 01/2014
1	Dipyridamole (Persantine)FDA LinkGeneric 01/2014
1	NucleosidesIBA 01/2014

Therapy/Procedure

1	Therapeutics 02/2023